Health Canada approves additional COVID-19 indication for Actemra® IV (tocilizumab)

Oct 28, 2022

Roche Canada announced that Health Canada has approved Actemra® IV (tocilizumab) for the treatment of hospitalised adult patients with COVID-19 who are receiving systemic corticosteroids, and require supplemental oxygen, non-invasive or invasive mechanical ventilation or extracorporeal membrane oxygenation.

Print Page Mail Article